4847

    543308

    KIMS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    KRISHNA INST OF MED SCI L Share Price Today

    KRISHNA INST OF MED SCI L is currently trading at ₹797.8, down by ₹5.15 from the previous close. The stock touched an intraday high of ₹802.45 and a low of ₹790.45 during the latest trading session. Over the past one year, KRISHNA INST OF MED SCI L has delivered a return of 8.26%, while the stock has gained 0.82% in the last one month.

    KRISHNA INST OF MED SCI L performance

    Today’s low Today’s high
    ₹ 790.45 ₹ 802.45
    ₹ 799.55
    52 week low 52 week high
    ₹ 575.80 ₹ 858.00
    ₹ 799.55
    Open Price ₹ 799.05
    Prev. Close ₹ 802.95
    Volume (Shares) 8180.00
    Total traded value ₹ 65.40
    Upper Circuit ₹ 963.50
    Lower Circuit ₹ 642.40
    info

    Investment Returns

    Over 1 Month 0.82% Over 3 Months 17.70% Over 6 Months 31.40% Over 1 Year 8.26%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    KRISHNA INST OF MED SCI L fundamentals


    • Market cap (Cr) 33,560.60
    • P/E Ratio (TTM) 129.22
    • Beta 0.78
    • Book Value / share 93.53
    • Return on equity 15.02%
    • EPS (TTM) 6.33
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 65.90
    info icon alternate text
    • Market cap (Cr) 33,354.80
    • P/E Ratio (TTM) 129.22
    • Beta 0.62
    • Book Value / share 93.53
    • Return on equity 15.02%
    • EPS (TTM) 6.33
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 65.90
    info icon alternate text

    KRISHNA INST OF MED SCI L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 456.20
    Operating Expense 378.00
    Net Profit 65.90
    Net Profit Margin (%) 14.44
    Earnings Per Share (EPS) 1.65
    EBITDA 141.39
    Effective Tax Rate (%) 26.03
    Particulars DEC 2025 (Values in Cr)
    Revenue 441.90
    Operating Expense 358.40
    Net Profit 72.50
    Net Profit Margin (%) 16.40
    Earnings Per Share (EPS) 1.81
    EBITDA 142.00
    Effective Tax Rate (%) 25.86
    Particulars SEP 2025 (Values in Cr)
    Revenue 430.00
    Operating Expense 356.10
    Net Profit 63.50
    Net Profit Margin (%) 14.76
    Earnings Per Share (EPS) 1.59
    EBITDA 124.39
    Effective Tax Rate (%) 26.24
    Particulars JUN 2025 (Values in Cr)
    Revenue 373.40
    Operating Expense 305.90
    Net Profit 58.80
    Net Profit Margin (%) 15.74
    Earnings Per Share (EPS) 1.47
    EBITDA 109.70
    Effective Tax Rate (%) 26.22
    Particulars MAR 2025 (Values in Cr)
    Revenue 345.90
    Operating Expense 260.40
    Net Profit 93.50
    Net Profit Margin (%) 27.03
    Earnings Per Share (EPS) 2.34
    EBITDA 143.70
    Effective Tax Rate (%) 22.40
    Particulars MAR 2026 (Values in Cr)
    Revenue 1701.50
    Operating Expense 1398.40
    Net Profit 260.70
    Net Profit Margin (%) 15.32
    Earnings Per Share (EPS) 6.52
    EBITDA 517.50
    Effective Tax Rate (%) 26.08
    Particulars MAR 2025 (Values in Cr)
    Revenue 1384.10
    Operating Expense 1048.50
    Net Profit 302.90
    Net Profit Margin (%) 21.88
    Earnings Per Share (EPS) 7.57
    EBITDA 484.00
    Effective Tax Rate (%) 24.85
    Particulars MAR 2024 (Values in Cr)
    Revenue 1222.10
    Operating Expense 922.10
    Net Profit 235.30
    Net Profit Margin (%) 19.25
    Earnings Per Share (EPS) 29.41
    EBITDA 379.90
    Effective Tax Rate (%) 26.05
    Particulars MAR 2023 (Values in Cr)
    Revenue 1132.02
    Operating Expense 818.18
    Net Profit 252.49
    Net Profit Margin (%) 22.30
    Earnings Per Share (EPS) 31.55
    EBITDA 383.78
    Effective Tax Rate (%) 25.15
    Particulars MAR 2022 (Values in Cr)
    Revenue 1143.38
    Operating Expense 796.55
    Net Profit 278.37
    Net Profit Margin (%) 24.34
    Earnings Per Share (EPS) 35.04
    EBITDA 420.39
    Effective Tax Rate (%) 24.97
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 53.45
    ROE % 20.92
    ROCE % 16.34
    Total Debt to Total Equity 0.99
    EBITDA Margin 27.53
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 228.46
    ROE % 19.21
    ROCE % 18.40
    Total Debt to Total Equity 0.58
    EBITDA Margin 26.45
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 208.62
    ROE % 23.93
    ROCE % 25.90
    Total Debt to Total Equity 0.31
    EBITDA Margin 29.64
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 173.35
    ROE % 29.70
    ROCE % 32.75
    Total Debt to Total Equity 0.25
    EBITDA Margin 33.40
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 111.32
    ROE % 23.33
    ROCE % 25.51
    Total Debt to Total Equity 0.47
    EBITDA Margin 29.01
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 54.20
    ROE % 15.02
    ROCE % 16.75
    Total Debt to Total Equity 0.26
    EBITDA Margin 35.29
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 233.30
    ROE % 13.46
    ROCE % 16.77
    Total Debt to Total Equity 0.09
    EBITDA Margin 31.40
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 203.79
    ROE % 16.79
    ROCE % 22.23
    Total Debt to Total Equity 0.01
    EBITDA Margin 34.22
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 172.13
    ROE % 24.15
    ROCE % 30.50
    Total Debt to Total Equity 0.07
    EBITDA Margin 37.16
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 116.93
    ROE % 21.42
    ROCE % 25.83
    Total Debt to Total Equity 0.21
    EBITDA Margin 34.01
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 79.70
    Total Assets 5736.00
    Total Liabilities 5736.00
    Total Equity 2418.80
    Share Outstanding 40
    Price to Book Ratio 11.80
    Return on Assets (%) 6.70
    Return on Capital (%) 8.89
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 49.00
    Total Assets 3851.70
    Total Liabilities 3851.70
    Total Equity 2093.10
    Share Outstanding 8
    Price to Book Ratio 8.82
    Return on Assets (%) 8.04
    Return on Capital (%) 9.87
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 66.37
    Total Assets 2941.30
    Total Liabilities 2941.30
    Total Equity 1937.96
    Share Outstanding 8
    Price to Book Ratio 6.90
    Return on Assets (%) 11.43
    Return on Capital (%) 13.61
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 190.06
    Total Assets 1907.34
    Total Liabilities 1907.34
    Total Equity 1410.64
    Share Outstanding 8
    Price to Book Ratio 8.02
    Return on Assets (%) 17.44
    Return on Capital (%) 21.17
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 284.44
    Total Assets 1436.15
    Total Liabilities 1436.15
    Total Equity 876.19
    Share Outstanding 7
    Price to Book Ratio 0.00
    Return on Assets (%) 14.01
    Return on Capital (%) 17.55
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 29.50
    Total Assets 3189.10
    Total Liabilities 3189.10
    Total Equity 2168.00
    Share Outstanding 40
    Price to Book Ratio 11.80
    Return on Assets (%) 9.49
    Return on Capital (%) 10.53
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 20.50
    Total Assets 2396.60
    Total Liabilities 2396.60
    Total Equity 1866.40
    Share Outstanding 8
    Price to Book Ratio 8.82
    Return on Assets (%) 9.81
    Return on Capital (%) 10.73
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 40.10
    Total Assets 1812.06
    Total Liabilities 1812.06
    Total Equity 1630.85
    Share Outstanding 8
    Price to Book Ratio 6.90
    Return on Assets (%) 13.93
    Return on Capital (%) 15.44
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 179.76
    Total Assets 1568.78
    Total Liabilities 1568.78
    Total Equity 1377.54
    Share Outstanding 8
    Price to Book Ratio 8.02
    Return on Assets (%) 17.74
    Return on Capital (%) 19.94
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 250.01
    Total Assets 1213.72
    Total Liabilities 1213.72
    Total Equity 907.32
    Share Outstanding 7
    Price to Book Ratio 0.00
    Return on Assets (%) 15.54
    Return on Capital (%) 18.4
    Particulars MAR 2025 (Values in Cr)
    Net Income 558.10
    Cash from Operations 723.20
    Cash from Investing -1116.20
    Cash from Financing 543.10
    Net change in Cash 8.70
    Free Cash Flow 1732.10
    Particulars MAR 2024 (Values in Cr)
    Net Income 459.63
    Cash from Operations 661.23
    Cash from Investing -752.56
    Cash from Financing 216.75
    Net change in Cash -14.72
    Free Cash Flow 1308.57
    Particulars MAR 2023 (Values in Cr)
    Net Income 484.90
    Cash from Operations 529.32
    Cash from Investing -546.89
    Cash from Financing 19.64
    Net change in Cash -95.16
    Free Cash Flow 1103.84
    Particulars MAR 2022 (Values in Cr)
    Net Income 456.85
    Cash from Operations 450.92
    Cash from Investing -411.51
    Cash from Financing 60.99
    Net change in Cash -26.49
    Free Cash Flow 621.24
    Particulars MAR 2021 (Values in Cr)
    Net Income 279.01
    Cash from Operations 393.71
    Cash from Investing -354.17
    Cash from Financing 9.81
    Net change in Cash 11.61
    Free Cash Flow 488.14
    Particulars MAR 2025 (Values in Cr)
    Net Income 403.10
    Cash from Operations 383.40
    Cash from Investing -626.60
    Cash from Financing 338.60
    Net change in Cash 5.60
    Free Cash Flow 735.09
    Particulars MAR 2024 (Values in Cr)
    Net Income 318.20
    Cash from Operations 347.70
    Cash from Investing -568.60
    Cash from Financing 288.60
    Net change in Cash -17.60
    Free Cash Flow 668.59
    Particulars MAR 2023 (Values in Cr)
    Net Income 337.33
    Cash from Operations 345.56
    Cash from Investing -237.66
    Cash from Financing -15.13
    Net change in Cash 18.24
    Free Cash Flow 466.55
    Particulars MAR 2022 (Values in Cr)
    Net Income 371.00
    Cash from Operations 380.65
    Cash from Investing -375.08
    Cash from Financing 75.98
    Net change in Cash -14.72
    Free Cash Flow 450.12
    Particulars MAR 2021 (Values in Cr)
    Net Income 254.26
    Cash from Operations 334.06
    Cash from Investing -316.60
    Cash from Financing 25.37
    Net change in Cash 0.11
    Free Cash Flow 406.73
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8821.25 64.84 13.39 126836.04 6680.00 9008.90
    FORTIS MALAR HOSPITALS LIMITED 50.22 22.72 2.74 94.12 40.75 76.00
    SHREE PACETRONIX LTD. 144.75 17.27 3.04 54.28 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.03 0.00 2.73 22.96 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8821.25 84.49 12.73 126836.04 6680.00 9008.90
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 37.93 0.00 -9.22 28.33 30.30 57.48
    KOVAI MEDICAL CENTER & HOSPITA 5988.25 26.80 4.96 6551.15 5010.00 6725.00

    KRISHNA INST OF MED SCI L shareholding pattern

    Holding
    18.82%
    34.11%
    14.57%
    32.49%
    10.26%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    KRISHNA INST OF MED SCI L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    799.05 -0.48 redarrow
    red-green-graph indicator
    10 Bearish
    6 Bullish
    • 5 Days 805.60
    • 26 Days 800.40
    • 10 Days 808.00
    • 50 Days 778.00
    • 12 Days 808.10
    • 100 Days 744.10
    • 20 Days 804.90
    • 200 Days 711.90
    803.35 PIVOT
    First Support 795.75 First Resistance 810.55 Second Support 788.55 Second Resistance 818.15 Third Support 780.95 Third Resistance 825.35
    RSI 51.45 ADX 20.06 MACD 7.70 Williams % R -80.96 Commodity Channel Index (CCI) -70.47
    Date 2026-07-17 Week 265366.00 Same Day 148891.00 Month 323572.00
    1 Year 0.77 3 Year 0.63
    Over 1 Month
    0.82% down
    Over 1 Year
    8.26% down
    Over 3 Months
    17.70% down
    Over 3 Years
    27.65% down
    Over 6 Months
    31.40% down
    Over 5 Years
    25.34% down

    KRISHNA INST OF MED SCI L Corporate Actions

    Ex-Date Old FV NEW FV Record Date
    13 Sep 2024 10.0 2.0 13 Sep 2024
    Ex-Date Old FV NEW FV Record Date
    13 Sep 2024 10.0 2.0 13 Sep 2024

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Krishna Institute of Medical Sciences Ltd?

    Answer Field

    Krishna Institute of Medical Sciences Ltd share price is for NSE ₹ 797.80 & for BSE ₹ 799.55 as on Jul 20 2026 09:57 AM.

    What is the Market Cap of Krishna Institute of Medical Sciences Ltd Share?

    Answer Field

    The market cap of Krishna Institute of Medical Sciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 20 2026 09:57 AM.

    What is the 52 Week High and Low of Krishna Institute of Medical Sciences Ltd?

    Answer Field

    The 52 Week High and Low of Krishna Institute of Medical Sciences Ltd for NSE is ₹ 858.00 and ₹ 575.80 and for BSE is ₹ 858.15 and ₹ 575.55.

    What is 1 year return for Krishna Institute of Medical Sciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 8.26%.

    What is the P/E Ratio of Krishna Institute of Medical Sciences Ltd Share?

    Answer Field

    As on Jul 20 2026 09:57 AM the price-to-earnings (PE) ratio for Krishna Institute of Medical Sciences Ltd share is 129.22.

    What is the PB ratio of Krishna Institute of Medical Sciences Ltd Share?

    Answer Field

    As on Jul 20 2026 09:57 AM, the price-to-book (PB) ratio for Krishna Institute of Medical Sciences Ltd share is 93.53.

    How to Buy Krishna Institute of Medical Sciences Ltd Share?

    Answer Field

    You can trade in Krishna Institute of Medical Sciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Krishna Institute of Medical Sciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Krishna Institute of Medical Sciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Krishna Institute of Medical Sciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |